Allozymes Analysis

Screen 20 million enzyme variants daily to identify high-performance enzymes; Develop sustainable pharmaceuticals using enzyme-driven small molecule production; Create novel soluble fiber from food side streams to reduce diabetes and obesity risks; Design bioprocesses for chemical industry to reduce environmental impact; Engineer enzymes for bioremediation and waste cleanup; Develop sustainable cosmetic ingredients with reduced chemical reliance

Allozymes is targeting several primary market focus areas, including:

• Pharmaceuticals: Developing enzymes for more efficient small molecule development and production.
• Life Sciences & Diagnostics: Creating next-generation enzymes for various applications.
• Food & Nutrition: Upcycling food companies' side streams into soluble fiber to combat diabetes and obesity.
• Chemical: Developing bioprocesses to lessen environmental impact.
• Bioremediation: Exploring enzymes for environmental cleanup.
• Personal Care: Creating sustainable cosmetic ingredients.

Allozymes has developed several key innovations and products in the biotech sector, including:

• A proprietary ultra-high-throughput microfluidics platform that enables the rapid development and screening of enzymes, analyzing over 20 million variants per day.
• Enzymes designed for efficient small molecule development in pharmaceuticals, promoting sustainability.
• Next-generation enzymes for life science and diagnostic applications, enhancing accuracy and scope.
• Proprietary enzymes that upcycle food companies' side streams into soluble fiber, addressing issues related to diabetes and obesity.
• Eco-friendly enzyme solutions for bioremediation and waste management.
• Aiming to build the world's largest enzyme data library to support sustainable industrial processes and democratize access to enzymatic solutions.

Allozymes, a Singapore-based biotechnology company, raised $15 million in a Series A funding round. This funding was announced on May 15, 2024, and was led by Seventure Partners and Xora Innovation. The company aims to utilize this investment to enhance its enzyme discovery and engineering capabilities.

Allozymes is targeting several primary market focus areas, including:

• Pharmaceuticals: Developing enzymes for more efficient small molecule development and production.
• Life Sciences & Diagnostics: Creating next-generation enzymes for various applications.
• Food & Nutrition: Upcycling food companies' side streams into soluble fiber to combat diabetes and obesity.
• Chemical: Developing bioprocesses to lessen environmental impact.
• Bioremediation: Exploring enzymes for environmental cleanup.
• Personal Care: Creating sustainable cosmetic ingredients.

Allozymes has received several awards and recognitions in the biotech field, including:

1. The Future Food Asia Award, which they won in recognition of their innovative contributions to the food industry.
2. They were recognized for having the Most Innovative Service or Technology Supporting Food & Beverage for their proprietary enzyme engineering technology.
3. They were finalists for the Innovation Awards 2022.

Allozymes has established several significant partnerships in the biotech industry, including:

1. Collaboration with Bonumose: Announced on March 31, 2025, this partnership aims to accelerate enzyme innovations for beneficial food and supplement ingredients. Source

2. Partnership with Adisseo: This strategic partnership focuses on next-generation animal feed production using rapid microfluidics technology, announced approximately 7 months ago. Source

3. Joint Venture with Syensqo: This collaboration aims to pioneer enzyme-powered personal care and skin care biosolutions, leveraging both companies' strengths in biotechnology and market reach. Source

4. Partnership with GenScript: This collaboration focuses on accelerating protein discovery and target identification, announced on December 7, 2022. Source

5. Membership in the Enzyme Technology Alliance: Allozymes was welcomed into this alliance, which includes various players in the enzyme technology space, announced on October 18, 2023. Source

Prevents 6.4M liters of biohazard waste and 6,400 tons of plastic waste; Backed by XORA, SOSV, TI Platform, Entrepreneur First, Seventure, Thia Ventures, and NUS; Commercial partner with Adisseo (Bluestar Company)

Allozymes has received several awards and recognitions in the biotech field, including:

1. The Future Food Asia Award, which they won in recognition of their innovative contributions to the food industry.
2. They were recognized for having the Most Innovative Service or Technology Supporting Food & Beverage for their proprietary enzyme engineering technology.
3. They were finalists for the Innovation Awards 2022.

Allozymes has established several significant partnerships in the biotech industry, including:

1. Collaboration with Bonumose: Announced on March 31, 2025, this partnership aims to accelerate enzyme innovations for beneficial food and supplement ingredients. Source

2. Partnership with Adisseo: This strategic partnership focuses on next-generation animal feed production using rapid microfluidics technology, announced approximately 7 months ago. Source

3. Joint Venture with Syensqo: This collaboration aims to pioneer enzyme-powered personal care and skin care biosolutions, leveraging both companies' strengths in biotechnology and market reach. Source

4. Partnership with GenScript: This collaboration focuses on accelerating protein discovery and target identification, announced on December 7, 2022. Source

5. Membership in the Enzyme Technology Alliance: Allozymes was welcomed into this alliance, which includes various players in the enzyme technology space, announced on October 18, 2023. Source